Search

everythinglearnresearchcommunity

for

Search:↓

Scalp disease in dermatomyositis causes significant symptoms and has unique features.

Most patients with cutaneous dermatomyositis either improved or remained stable over 3.5 years.

Apremilast shows promise for several skin conditions but needs more research.

Psoriasis patients experience moderate functional impairment related to disease severity and less satisfaction.

Cannabinoids may help some skin conditions but more research is needed.

Cannabinoids like CBD and THC may help treat non-cancer skin diseases, but more research is needed.

JAK inhibitors show promise for treating skin and hair disorders but need more research on long-term safety and effectiveness.

10% carbamide peroxide is safe and effectively reduces mild to moderate acne.

People with hidradenitis suppurativa who are more resilient tend to have better quality of life and less anxiety and depression.

Laser treatment may help with hair growth in some people with frontal fibrosing alopecia, but results vary and the exact way it works is unclear.

Using a teletriage system greatly increased access to skin care for uninsured Latino immigrants at a clinic.

JAK inhibitors help with skin conditions but need more research on dosing and safety.

The JAK/STAT pathway is important in cell processes and disease, and JAK inhibitors are promising for treating related conditions.

JAK inhibitors show promise for treating skin conditions like eczema, hair loss, and psoriasis.

The document concludes that better tools are needed to measure skin disease severity in dermatomyositis and cutaneous lupus erythematosus, and introduces the DSSI and CLASI as reliable instruments.

CLASI is a valid tool for assessing skin activity and damage in lupus patients.

The CLASI is a reliable tool for measuring the severity of cutaneous lupus erythematosus.

Type I interferons play a key role in the development of various skin diseases.

Skin disease activity scores can help decide when skin symptoms no longer affect the quality of life in patients with mild dermatomyositis.

The document concludes that recognizing and treating cutaneous lupus erythematosus early is crucial for managing the skin and potential systemic symptoms.

Skin problems are common in Lupus patients and can indicate the disease's severity, requiring specific treatments and lifestyle changes.

Lupus is a complex disease that requires personalized treatment because it varies greatly between individuals.

Skin problems are common in lupus, often appearing first, with various types and treatments, and careful monitoring is important for diagnosis and management.

Skin problems are common in lupus patients and should be treated early to prevent worsening.

Many patients with cutaneous lupus erythematosus experience hair loss and nail problems, which are important for diagnosis and treatment.

Topical calcineurin inhibitors, especially 0.1% tacrolimus ointment, are effective and well-tolerated for treating cutaneous lupus erythematosus but require more research for standard treatment guidelines.

Lupus can cause different skin problems, and treatments like quitting smoking and using certain creams or medicines can help.

The document is a detailed medical reference on skin and genetic disorders.

Various skin conditions like cutaneous lupus erythematosus, psoriasis, and basal cell carcinoma can be effectively treated with antihypertensive agents, NB-UVB phototherapy, and imiquimod cream respectively. Vaccines are effective against genital herpes and HPV-16 infection. Early intervention is crucial for conditions like diabetic foot ulcers and neonatal herpes. Certain dyes can cause hand dermatitis, and there's a link between smoking/drinking and psoriasis in men. No direct link was found between low iron levels and chronic hair loss in women.

The document concludes that various treatments for skin conditions are effective, but some require further research, and certain factors like gender and lifestyle can influence disease outcomes.